Gelsolin Promotes Cancer Progression by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma and Correlates with a Poor Prognosis.

In conclusion, GSN promotes cancer progression and is associated with a poor prognosis in HCC patients. GSN promotes HCC progression by regulating EMT. PMID: 32377190 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32377190?dopt=Abstract

Source: Journal of Oncology - May 8, 2020 Category: Cancer & Oncology Tags: J Oncol Source Type: research